<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1917">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05136209</url>
  </required_header>
  <id_info>
    <org_study_id>CCPMOH2021-China12</org_study_id>
    <nct_id>NCT05136209</nct_id>
  </id_info>
  <brief_title>Comparison of Posterior Continuous Curvilinear Capsulorhexis With or Without Anterior Vitrectomy</brief_title>
  <official_title>Comparison of Posterior Continuous Curvilinear Capsulorhexis With or Without Anterior Vitrectomy in Congenital Cataract Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sun Yat-sen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sun Yat-sen University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Selecting the appropriate surgical approach for congenital cataracts presents challenging for&#xD;
      ophthalmologists. This prospective, randomized controlled study aims to compare the prognosis&#xD;
      of posterior continuous curvilinear capsulorhexis (PCCC) with or without anterior vitrectomy&#xD;
      (A-Vit) in treating congenital cataracts.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Due to the particularity of children's eye structure, selecting the appropriate surgical&#xD;
      approach for congenital cataracts presents challenging for ophthalmologists. The major&#xD;
      concerned postoperative problem is the after-cataract formation. As a result, PCCC with A-Vit&#xD;
      is usually performed to prevent the formation of secondary cataracts. However. Debate over&#xD;
      the indication and surgical procedure still persists since A-Vit and excessive manipulations&#xD;
      may interfere with the development of the eye and increase the risk of postoperative&#xD;
      inflammation, unstable intraocular pressure, macular edema, retinal detachment and so on.&#xD;
      Thus, it is necessary to evaluate the safety and effectiveness of PCCC without A-Vit in&#xD;
      congenital cataract surgery.&#xD;
&#xD;
      In this randomized clinical trial, children with equal degree of congenital cataract in both&#xD;
      eyes are enrolled. Patients receive cataract surgery on both eyes on the same day. For each&#xD;
      patient, one eye is randomly assigned to undergo PCCC+A-Vit procedure, while the fellow eye&#xD;
      is undergoing PCCC procedure without A-Vit. PCCC+A-Vit procedure includes anterior continuous&#xD;
      curvilinear capsulorhexis (ACCC), irrigation/aspiration (I/A), PCCC, and A-Vit. Primary&#xD;
      intraocular lens implantation (IOL) is performed in children older than age of two.&#xD;
      Investigators then compare the incidence of visual axis opacity, uveitis, iris/pupil&#xD;
      abnormality and intraocular pressure between two groups.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2021</start_date>
  <completion_date type="Anticipated">November 1, 2026</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2026</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of participants with visual axis opacification</measure>
    <time_frame>5 years</time_frame>
    <description>Number of participants with visual axis opacification evaluated based on the retro-illumination.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of participants with uveitis and iris/pupil abnormality</measure>
    <time_frame>5 years</time_frame>
    <description>Number of participants with uveitis and iris/pupil abnormality evaluated based on the slip lamp examination.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>IOP</measure>
    <time_frame>5 years</time_frame>
    <description>Intraocular pressure measured by the Tono-pen or non-contact tonometer</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>BCVA change</measure>
    <time_frame>5 years</time_frame>
    <description>Change from baseline in the best corrected visual acuity (BCVA) measured by the Teller's acuity card, the Lea symbol visual acuity chart or the ETDRS chart according the patient's age.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AL change</measure>
    <time_frame>5 years</time_frame>
    <description>Change from baseline in axial length measured by AL-Scan, IOLMaster or A-scan</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CCT change</measure>
    <time_frame>5 years</time_frame>
    <description>Change from baseline in the central corneal thickness (CCT) measured by pentacam.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CFT change</measure>
    <time_frame>5 years</time_frame>
    <description>Change from baseline in the central foveal thickness (CFT) measured by Optical Coherence Tomography (OCT)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Congenital Cataract</condition>
  <arm_group>
    <arm_group_label>PCCC procedure without A-vit</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Procedure/Surgery: PCCC procedure without A-vit ACCC + I / A + PCCC or ACCC + I / A +PCCC + IOL</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PCCC+A-Vit procedure</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Procedure/Surgery: PCCC+A-Vit procedure ACCC + I / A + PCCC + A-vit or ACCC + I / A +PCCC + IOL + A-vit</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>PCCC procedure without A-vit</intervention_name>
    <description>In this randomized clinical trial, patients receive cataract surgery on both eyes on the same day. For each patient, one eye is randomly assigned to undergo PCCC+A-Vit procedure, while the fellow eye is undergoing PCCC procedure without A-Vit.</description>
    <arm_group_label>PCCC procedure without A-vit</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>PCCC+A-Vit procedure</intervention_name>
    <description>PCCC+A-Vit procedure</description>
    <arm_group_label>PCCC+A-Vit procedure</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Children with bilateral congenital cataracts without other ocular abnormalities&#xD;
&#xD;
          -  Gestational age at birth &gt;37 weeks&#xD;
&#xD;
          -  No more than 18 years old&#xD;
&#xD;
          -  Pupils could dilate normally pre-operation&#xD;
&#xD;
          -  Have signed a consent form&#xD;
&#xD;
          -  Can be followed&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Intraocular pressure &gt;21 mmHg&#xD;
&#xD;
          -  History of ocular trauma and intraocular surgery&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Month</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Weirong Chen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Zhongshan Ophthalmic Center, Sun Yat-sen University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tingfeng Qin</last_name>
    <phone>13724104066</phone>
    <email>qintf3@mail2.sysu.edu.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>Zhongshan Ophthalmic Center, Sun Yat-sen University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510080</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tingfeng Qin</last_name>
      <phone>13724104066</phone>
      <email>qintf3@mail2.sysu.edu.cn</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 11, 2021</study_first_submitted>
  <study_first_submitted_qc>November 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 29, 2021</study_first_posted>
  <last_update_submitted>November 25, 2021</last_update_submitted>
  <last_update_submitted_qc>November 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sun Yat-sen University</investigator_affiliation>
    <investigator_full_name>Haotian Lin</investigator_full_name>
    <investigator_title>Prof.</investigator_title>
  </responsible_party>
  <keyword>Congenital cataract surgery</keyword>
  <keyword>anterior vitrectomy</keyword>
  <keyword>postoperative complications</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

